Oxidative upregulation of Bcl-2 in healthy lymphocytes

Annals of the New York Academy of Sciences

Volumn 1091, Issue , 2006, Pages 1-9

  Cristofanon, Silvia ^a,b   Nuccitelli, Silvia ^b   D'Alessio, Maria ^b   Radogna, Flavia ^b   De Nicola, Milena ^b   Bergamaschi, Antonio ^c   Cerella, Claudia ^b   Magrini, Andrea ^c   Diederich, Marc ^a   Ghibelli, Lina ^b  

^a LABORATOIRE DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE DU CANCER   (Luxembourg)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Apoptosis; Bcl 2; Buthionine sulfoximine; Glutathione; Lymphocyte

Indexed keywords

BUTHIONINE SULFOXIMINE; GLUTATHIONE; PROTEIN BCL 2; ANTINEOPLASTIC ANTIMETABOLITE;

BLOOD; CELL CULTURE; CELL ISOLATION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; OXIDATION REDUCTION POTENTIAL; OXIDATION REDUCTION STATE; PROTEIN DEPLETION; SEPARATION TECHNIQUE; UPREGULATION; ADULT; ARTICLE; BIOSYNTHESIS; CELL SEPARATION; DRUG EFFECT; GENETICS; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY; TUMOR CELL LINE;

ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; BUTHIONINE SULFOXIMINE; CELL LINE, TUMOR; CELL SEPARATION; CELLS, CULTURED; FEMALE; HUMANS; LYMPHOCYTES; MALE; OXIDATION-REDUCTION; PROTO-ONCOGENE PROTEINS C-BCL-2; UP-REGULATION;

EID: 33947583288     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1378.049     Document Type: Conference Paper

References (18)

1. LORENZI, M., D.F. MONTISANO, S. TOLEDO & H.C. WONG. 1987. Increased single strand breaks in DNA of lymphocytes from diabetic subjects. J. Clin. Invest. 79: 653-656.
2. LORENZI, M., J.A. NORDBERG & S. TOLEDO. 1987. High glucose prolongs cell-cycle traversal of cultured human endothelial cells. Diabetes 36: 1261-1267.
3. VOEHRINGER, D.W. 1999. BCL-2 and glutathione: alterations in cellular redox state that regulate apoptosis sensitivity. Free Radic. Biol. Med. 27: 945-950.
4. REBER, U., U. WULLNER, M. TREPEL, et al. 1998. Potentiation of treosulfan toxicity by the glutathione-depleting agent buthionine sulfoximine in human malignant glioma cells: the role of bcl-2. Biochem. Pharmacol. 55: 349-359.
5. RAPPA, G., M.P. GAMCSIK, R.L. MITINA, et al. 2003. Retroviral transfer of MRP1 and gamma-glutamyl cysteine synthetase modulates cell sensitivity to L-buthionine-S,R-sulphoximine (BSO): new rationale for the use of BSO in cancer therapy. Eur. J. Cancer 39: 120-128.
6. GHIBELLI, L., C. FANELLI, G. ROTILIO, et al. 1998. Rescue of cells from apoptosis by inhibition of active GSH extrusion. FASEB J. 12: 479-486.
7. D'ALESSIO, M., C. CERELLA, C. AMICI, et al. 2004. Glutathione depletion upregulates Bcl-2 in BSO-resistant cells. FASEB J. 18: 1609-1611.
8. SCHATTNER, E.J. 2002. Apoptosis in lymphocytic leukemias and lymphomas. Cancer Invest. 20: 737-748.
9. CASINI, A.F., A. POMPELLA & M. COMPORTI. 1984. Glutathione depletion, lipid peroxidation, and liver necrosis following bromobenzene and iodobenzene intoxication. Toxicol. Pathol. 12: 295-299.
10. TREUMER, J. & G. VALET. 1986. Flow-cytometric determination of glutathione alterations in vital cells by o-phthaldialdehyde (OPT) staining. Exp. Cell Res. 163: 518-524.
11. CELLI, A., F.G. QUE, G.J. GORES & N.F. LARUSSO. 1998. Glutathione depletion is associated with decreased Bcl-2 expression and increased apoptosis in cholangiocytes. Am. J. Physiol. 275: G749-G757.
12. AKBAR, A.N., N.J. BORTHWICK, R.G. W ICKREMASINGHE, et al. 1996. Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of antiapoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression. Eur. J. Immunol. 26: 294-299.
13. KATOH, S., Y. MITSUI, K. KITANI & T. SUZUKI. 1996. Nerve growth factor rescues PC12 cells from apoptosis by increasing amount of bcl-2. Biochem. Biophys. Res. Commun. 229: 653-657.
14. SANDAU, K.B. & B. BRUNE. 2000. Up-regulation of Bcl-2 by redox signals in glomerular mesangial cells. Cell Death Differ. 7: 118-125.
15. ZHOU, L.Z., A.P. JOHNSON & T.A. RANDO. 2001. NF kappa B and AP-1 mediate transcriptional responses to oxidative stress in skeletal muscle cells. Free Radic. Biol. Med. 31: 1405-1416.
16. LI, X. & G.R. STARK. 2002. NFkappaB-dependent signaling pathways. Exp. Hematol. 30: 285-296.
17. HEISSMEYER, V., D. KRAPPMANN, F.G. WULCZYN & C. SCHEIDEREIT. 1999. NFkappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes. EMBO J. 18: 4766-4778.
18. KURLAND, J.F., R. KODYM, M.D. STORY, et al. 2001. NF-kappaB1 (p50) homodimers contribute to transcription of the bcl-2 oncogene. J. Biol. Chem. 276: 45380-45386.